Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment ; volume:18 ; number:1 ; day:30 ; month:3 ; year:2019 ; pages:1-19 ; date:12.2019
Molecular cancer ; 18, Heft 1 (30.3.2019), 1-19, 12.2019
- Urheber
-
Cheng, Hong Sheng
Lee, Jeannie Xue Ting
Wahli, Walter
Tan, Nguan Soon
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-019-0971-9
- URN
-
urn:nbn:de:101:1-2019042112291773507059
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cheng, Hong Sheng
- Lee, Jeannie Xue Ting
- Wahli, Walter
- Tan, Nguan Soon
- SpringerLink (Online service)
Ähnliche Objekte (12)
Understanding, inducing and exploiting actionable vulnerabilities in experimental glioma
Exploiting molecular vulnerabilities in genetically defined lung cancer models
Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality
Exploiting metabolic vulnerabilities caused by autophagy defects for cancer therapy
Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
Vulnerabilities
Exploiting vulnerabilities of bromodomain-containing chromatin remodelling complexes BAF and PBAF using inhibitors and PROTACs
Exploiting the ubiquitin system to identify novel vulnerabilities in B-cell malignancies and lung adenocarcinoma
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics
Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy
Understanding, inducing and exploiting actionable vulnerabilities in experimental glioma
Exploiting molecular vulnerabilities in genetically defined lung cancer models
Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality
Exploiting metabolic vulnerabilities caused by autophagy defects for cancer therapy
Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
Vulnerabilities
Exploiting vulnerabilities of bromodomain-containing chromatin remodelling complexes BAF and PBAF using inhibitors and PROTACs
Exploiting the ubiquitin system to identify novel vulnerabilities in B-cell malignancies and lung adenocarcinoma
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics
Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy
Understanding, inducing and exploiting actionable vulnerabilities in experimental glioma
Exploiting molecular vulnerabilities in genetically defined lung cancer models
Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality
Exploiting metabolic vulnerabilities caused by autophagy defects for cancer therapy
Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
Vulnerabilities
Exploiting vulnerabilities of bromodomain-containing chromatin remodelling complexes BAF and PBAF using inhibitors and PROTACs
Exploiting the ubiquitin system to identify novel vulnerabilities in B-cell malignancies and lung adenocarcinoma
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics